• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Impact of COVID-19 in Cystic Fibrosis.

作者信息

Flume Patrick A, Saiman Lisa, Marshall Bruce

机构信息

Medical University of South Carolina, Charleston, SC, USA.

Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Arch Bronconeumol. 2022 Jun;58(6):466-468. doi: 10.1016/j.arbres.2021.12.003. Epub 2021 Dec 17.

DOI:10.1016/j.arbres.2021.12.003
PMID:34934258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8679495/
Abstract
摘要

相似文献

1
The Impact of COVID-19 in Cystic Fibrosis.新型冠状病毒肺炎对囊性纤维化的影响
Arch Bronconeumol. 2022 Jun;58(6):466-468. doi: 10.1016/j.arbres.2021.12.003. Epub 2021 Dec 17.
2
Immunoglobulin A vasculitis in a child: Secondary to COVID-19 or cystic fibrosis?一名儿童的免疫球蛋白A血管炎：继发于新冠病毒感染还是囊性纤维化？
Pediatr Pulmonol. 2023 Feb;58(2):627-628. doi: 10.1002/ppul.26233. Epub 2022 Dec 20.
3
Is cystic fibrosis a risk factor for COVID-19 infection or related complications?囊性纤维化是新型冠状病毒肺炎感染或相关并发症的危险因素吗？
J Bras Pneumol. 2023 Jan 13;48(6):e20220445. doi: 10.36416/1806-3756/e20220445.
4
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis.关注 COVID-19 中的肺部疾病之外：囊性纤维化患者带来的启示。
Med Hypotheses. 2021 Feb;147:110481. doi: 10.1016/j.mehy.2020.110481. Epub 2021 Jan 4.
5
COVID-19 vaccine prioritisation for people with cystic fibrosis.针对囊性纤维化患者的新冠疫苗接种优先排序
J Cyst Fibros. 2021 Jul;20(4):715-716. doi: 10.1016/j.jcf.2021.03.028. Epub 2021 Apr 15.
6
Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: A multicenter retrospective research network study.SARS-CoV-2 感染在囊性纤维化患者中的结局：一项多中心回顾性研究网络研究。
Respir Med. 2021 Nov;188:106606. doi: 10.1016/j.rmed.2021.106606. Epub 2021 Sep 8.
7
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19.用于合并严重细胞因子血症 COVID-19 的囊性纤维化的 α-1 抗胰蛋白酶。
J Cyst Fibros. 2021 Jan;20(1):31-35. doi: 10.1016/j.jcf.2020.11.012. Epub 2020 Nov 20.
8
SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction?一名囊性纤维化患者感染严重急性呼吸综合征冠状病毒2和洋葱伯克霍尔德菌：不祥的组合？
J Cyst Fibros. 2021 May;20(3):e29-e31. doi: 10.1016/j.jcf.2021.03.024. Epub 2021 Apr 8.
9
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.儿童囊性纤维化患者感染 SARS-CoV-2 的临床特征：一项国际观察性研究。
J Cyst Fibros. 2021 Jan;20(1):25-30. doi: 10.1016/j.jcf.2020.11.021. Epub 2020 Dec 3.
10
COVID-19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis.新冠病毒感染和诺卡菌病导致一名患有囊性纤维化的青少年死亡。
Pediatr Pulmonol. 2022 Jul;57(7):1823-1825. doi: 10.1002/ppul.25954. Epub 2022 Jun 2.

引用本文的文献

1
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system.依列卡福妥/替扎卡福妥/依伐卡托的真实世界安全性概况：使用美国食品药品监督管理局不良事件报告系统的不成比例性分析
Front Pharmacol. 2025 Mar 12;16:1531514. doi: 10.3389/fphar.2025.1531514. eCollection 2025.
2
Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis: Exploring Therapeutic Options.流感、SARS-CoV-2 及其对慢性肺部疾病和纤维化的影响：探索治疗选择。
Am J Pathol. 2024 Oct;194(10):1807-1822. doi: 10.1016/j.ajpath.2024.06.004. Epub 2024 Jul 18.
3
Occurrence of COVID-19 in cystic fibrosis patients: a review.

本文引用的文献

1
Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs.评估美国囊性纤维化项目在 COVID-19 大流行期间远程医疗的障碍因素和促进因素。
J Cyst Fibros. 2021 Dec;20 Suppl 3:9-13. doi: 10.1016/j.jcf.2021.08.034.
2
Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors.COVID-19 期间囊性纤维化的远程医疗使用：与种族、民族和社会经济因素的关联。
J Cyst Fibros. 2021 Dec;20 Suppl 3:49-54. doi: 10.1016/j.jcf.2021.09.006.
3
Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis (Commentary).
囊性纤维化患者中新型冠状病毒肺炎的发生情况：一项综述
Front Microbiol. 2024 Apr 17;15:1356926. doi: 10.3389/fmicb.2024.1356926. eCollection 2024.
4
The cost of simplifying treatments for cystic fibrosis: Implications of the SIMPLIFY trial.简化囊性纤维化治疗的成本：SIMPLIFY 试验的意义。
J Manag Care Spec Pharm. 2024 Jan;30(1):26-33. doi: 10.18553/jmcp.2024.30.1.26.
5
Impact of COVID-19 pandemic on health care system, work, and mental well-being of people with cystic fibrosis.COVID-19 大流行对囊性纤维化患者的医疗保健系统、工作和心理健康的影响。
Ir J Med Sci. 2023 Dec;192(6):2961-2968. doi: 10.1007/s11845-023-03391-w. Epub 2023 May 12.
6
Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?患有囊性纤维化的肝移植和肺移植患者对SARS-CoV-2疫苗接种的免疫反应是否存在差异？
Vaccines (Basel). 2023 Mar 14;11(3):657. doi: 10.3390/vaccines11030657.
7
SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far.囊性纤维化患者的新型冠状病毒2型感染：目前我们所了解的情况。
Life (Basel). 2022 Dec 13;12(12):2087. doi: 10.3390/life12122087.
8
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients.依洛尤单抗治疗严重囊性纤维化肺病患者的真实疗效和安全性。
Pharmacol Res Perspect. 2022 Dec;10(6):e01015. doi: 10.1002/prp2.1015.
9
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.COVID-19 感染对既往呼吸道疾病的短期和长期影响。
Arch Bronconeumol. 2022 Apr;58 Suppl 1:39-50. doi: 10.1016/j.arbres.2022.03.011. Epub 2022 Apr 15.
2019冠状病毒病对心理健康的影响：对筛查、护理提供及囊性纤维化患者的影响（评论）
J Cyst Fibros. 2021 Dec;20 Suppl 3:39-40. doi: 10.1016/j.jcf.2021.08.006.
4
Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis.新冠疫情对心理健康的影响：对筛查、护理提供和囊性纤维化患者的影响。
J Cyst Fibros. 2021 Dec;20 Suppl 3:31-38. doi: 10.1016/j.jcf.2021.08.027.
5
Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic.设计和方法以了解在 COVID-19 大流行期间囊性纤维化护理的状况。
J Cyst Fibros. 2021 Dec;20 Suppl 3:3-8. doi: 10.1016/j.jcf.2021.08.028.
6
The life rafts sailed; Now let's take stock and set the course ahead (Commentary).救生筏启航了；现在让我们评估一下并确定前进的方向（评论）。
J Cyst Fibros. 2021 Dec;20 Suppl 3:29-30. doi: 10.1016/j.jcf.2021.08.022.
7
Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future.COVID-19 大流行对囊性纤维化护理的财务影响：未来的教训。
J Cyst Fibros. 2021 Dec;20 Suppl 3:16-20. doi: 10.1016/j.jcf.2021.09.008.
8
Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care (Commentary).囊性纤维化中的数字医疗。从疫情中汲取经验以创新未来护理（评论）
J Cyst Fibros. 2021 Dec;20 Suppl 3:64-66. doi: 10.1016/j.jcf.2021.09.003. Epub 2021 Sep 24.
9
Impact of COVID-19 on social determinants of health for adults with cystic fibrosis.COVID-19 对成年囊性纤维化患者健康社会决定因素的影响。
Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211037459. doi: 10.1177/17534666211037459.
10
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.在 COVID-19 期间减少住院 COPD 加重：系统评价和荟萃分析。
PLoS One. 2021 Aug 3;16(8):e0255659. doi: 10.1371/journal.pone.0255659. eCollection 2021.